Literature DB >> 9692841

The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer.

M Hirashima1, S Higuchi, K Sakamoto, T Nishiyama, H Okada.   

Abstract

We examined 55 patients (40 male, 15 female) who were diagnosed from 1987 to 1991 as having early gastric cancer (EGC) stage I according to the general rules of classification of the Japanese Research Society for Gastric Cancer. Of the 55 patients, 42 (30 male, 12 female) were alive in April 1992. The prognosis correlated well with the ratio of neutrophils to lymphocytes (N/L ratio) but not with the total number of white blood cells in the peripheral blood. The patients were divided into two groups according to their N/L ratio. Of the 29 patients with an N/L ratio less than 2, 27 were alive in 1992, whereas only 15 of the 26 patients with an N/L ratio of 2 or more were alive (chi2 analysis, P=0.0022). We further examined the phenotypes of neutrophils from 29 other patients with EGC at the time of diagnosis before surgical operation. These patients were divided into two groups: 17 patients with a low N/L ratio (less than 2) and 12 patients with a high N/L ratio (2 or more). CD10 and CD35 expressions on neutrophils from the patients with a low N/L ratio were lower than those from the patients with a high N/L ratio. The N/L ratio correlated well with both CD10 and CD35 expression, whereas no correlation was observed between the numbers of neutrophils and the expression of these phenotypes. The respiratory burst of neutrophils from the patients with a high N/L ratio was higher than that of neutrophils from the patients with a low N/L ratio, though there was no correlation in the phagocytic activity between both groups. It was thus suggested that the heterogeneity of neutrophils is, at least partly, related to the prognosis of patients with EGC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692841     DOI: 10.1007/s004320050178

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  30 in total

1.  Blood neutrophil-lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX 4.

Authors:  Lamiss Mohamed Abd el Aziz
Journal:  Med Oncol       Date:  2014-11-04       Impact factor: 3.064

2.  The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment.

Authors:  Mehmet Aliustaoglu; Ahmet Bilici; Bala Basak Oven Ustaalioglu; Volkan Konya; Murat Gucun; Mesut Seker; Mahmut Gumus
Journal:  Med Oncol       Date:  2009-10-22       Impact factor: 3.064

3.  Long-term outcomes and prognostic factors with non-curative endoscopic submucosal dissection for gastric cancer in elderly patients aged ≥ 75 years.

Authors:  Yosuke Toya; Masaki Endo; Shotaro Nakamura; Risaburo Akasaka; Shunichi Yanai; Keisuke Kawasaki; Keisuke Koeda; Makoto Eizuka; Yasuko Fujita; Noriyuki Uesugi; Kazuyuki Ishida; Tamotsu Sugai; Takayuki Matsumoto
Journal:  Gastric Cancer       Date:  2018-12-17       Impact factor: 7.370

4.  Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer.

Authors:  Liang Yu; Cheng-Yu Lv; Ai-Hua Yuan; Wei Chen; An-Wei Wu
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

5.  Prognostic value of carbohydrate tumor markers and inflammation-based markers in metastatic or recurrent gastric cancer.

Authors:  Qing Wang; Yang Yang; Ya-Ping Zhang; Zhengyun Zou; Xiaoping Qian; Baorui Liu; Jia Wei
Journal:  Med Oncol       Date:  2014-10-26       Impact factor: 3.064

6.  Prognostic significance of host- and tumor-related factors in patients with gastric cancer.

Authors:  Yasuhiko Mohri; Kouji Tanaka; Masaki Ohi; Takeshi Yokoe; Chikao Miki; Masato Kusunoki
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

7.  Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance status.

Authors:  Yoshio Ohno; Jun Nakashima; Makoto Ohori; Ayako Tanaka; Takeshi Hashimoto; Tatsuo Gondo; Tadashi Hatano; Masaaki Tachibana
Journal:  Int J Clin Oncol       Date:  2013-01-09       Impact factor: 3.402

8.  Prediction of chemotherapeutic efficacy using the ratio of neutrophils to lymphocytes in patients with unresectable or recurrent gastric cancer.

Authors:  Huanran Liu; Mingzhi Song; Fengqi Fang; Xue Gao; Zhen Zhang; Shouyu Wang
Journal:  Oncol Lett       Date:  2015-08-04       Impact factor: 2.967

9.  Comprehensive Analysis of the Neutrophil-to-Lymphocyte Ratio for Preoperative Prognostic Prediction Nomogram in Gastric Cancer.

Authors:  Jong-Ho Choi; Yun-Suhk Suh; Yunhee Choi; Jiyeon Han; Tae Han Kim; Shin-Hoo Park; Seong-Ho Kong; Hyuk-Joon Lee; Han-Kwang Yang
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

10.  The role of systemic inflammatory and nutritional blood-borne markers in predicting response to neoadjuvant chemotherapy and survival in oesophagogastric cancer.

Authors:  Fergus Noble; James Hopkins; Nathan Curtis; Jamie J Kelly; Ian S Bailey; James P Byrne; Adrian C Bateman; Andrew R Bateman; Timothy J Underwood
Journal:  Med Oncol       Date:  2013-05-21       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.